Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)-Reference-Cited by-同舟云学术

Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)

Published:2011-04 Issue:2 Volume:21 Page:122-133
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Yamanaka Hisashi,Tanaka Yoshiya,Inoue Eisuke,Hoshi Daisuke,Momohara Shigeki,Hanami Kentaro,Yunoue Naoki,Saito Kazuyoshi,Amano Kouichi,Kameda Hideto,Takeuchi Tsutomu

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/s10165-010-0366-7

Reference37 articles.

1. Evolving concepts of rheumatoid arthritis

2. Clinical Implications of Understanding Radiographic Findings in Relation to Clinical Outcomes in Rheumatoid Arthritis

3. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

4. Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations;Advanced Healthcare Materials;2024-03-15

2. Sialic-Acid-Related Enzymes of B Cells and Monocytes as Novel Markers to Discriminate Improvement Categories and to Fulfill Two Remission Definitions in Rheumatoid Arthritis;International Journal of Molecular Sciences;2023-08-20

3. A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects;Clinical and Translational Science;2023-07-18

4. Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies;Journal of Pharmacology and Pharmacotherapeutics;2022-12

5. Tocilizumab and its usage for skin diseases;Italian Journal of Dermatology and Venereology;2022-02